We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
PRIORIX-TETRA vaccine 0.5 mL powder for injection vial with diluent syringe, GlaxoSmithKline Australia Pty Ltd, CON-1082
Product name
PRIORIX-TETRA vaccine 0.5 mL powder for injection vial with diluent syringe
Sponsor name
GlaxoSmithKline Australia Pty Ltd
Consent start
Consent no.
CON-1082
Duration
The consent is effective from 9 March 2023 until 1 October 2026.
Standard
Section 6 and paragraph 10(3)(a) of Therapeutic Goods Order No. 91 - Standard for labels of prescription and related medicines
Non-compliance with standard
The excipient names on the labels do not align with the Australian Approved
Names and the quantity of all excipients is not specified on the label.
Import, Supply, &/or Export
import and supply
Therapeutic product type
Prescription medicines